HIV/AIDS — Ocular Manifestations

Overview

Ocular disease in HIV/AIDS falls into two broad categories that map onto different points in the natural history of untreated or undertreated infection. The first is a noninfectious microvasculopathy — HIV retinopathy — that arises directly from the systemic effects of the virus itself and can appear at almost any CD4 count. The second is a collection of opportunistic infections and malignancies that only emerge once cell-mediated immunity has collapsed past a specific threshold, most of them clustering below a CD4+ T-cell count of 50 cells/mm³. That threshold is what makes the eye clinically useful beyond just being a site of disease: the specific fundus finding in front of you is a reasonable proxy for how immunosuppressed the patient actually is, which matters both for diagnosis and for triaging urgency.

This dual pattern — one common but low-stakes finding present in the majority of patients, and several rarer but sight- and life-threatening findings concentrated in the most advanced disease — is the organizing idea behind everything below. Knowing which bucket a fundus finding belongs to, and roughly what CD4 count would be needed to produce it, is often enough to generate the right differential before any lab value comes back.

Clinical Features

HIV Retinopathy (Noninfectious Microvasculopathy)

HIV retinopathy is the single most common ocular manifestation of HIV/AIDS overall, occurring in up to 50–70% of infected patients — far more common than any opportunistic infection discussed below. It is not an infection of the retina itself but a microvasculopathy thought to relate to circulating immune complex deposition and increased plasma viscosity, producing capillary occlusion in the retinal nerve fiber layer. The classic findings are cotton wool spots (microinfarcts of the nerve fiber layer), scattered intraretinal hemorrhages, and microaneurysms — findings that can look superficially similar to diabetic or hypertensive retinopathy but occur here as a direct consequence of HIV infection.

Despite being the most frequently seen finding by a wide margin, HIV retinopathy is also the least clinically concerning: it is typically asymptomatic, does not threaten vision, and requires no treatment of its own beyond systemic antiretroviral therapy (ART) for the underlying infection. Its main practical value is as a sign to be recognized and distinguished from the infectious processes below, not treated in isolation.

CMV Retinitis

Cytomegalovirus (CMV) retinitis is the most common infectious retinitis in AIDS and the prototype opportunistic ocular infection. It classically occurs once the CD4+ T-cell count falls below 50 cells/mm³, and its fundus appearance is distinctive enough to be recognized on sight: a "pizza-pie" or "cottage cheese and ketchup" pattern of granular, hemorrhagic, full-thickness retinal necrosis, with intraretinal hemorrhage scattered through areas of white, opacified retina.

The single most useful bedside differentiator between CMV retinitis and toxoplasmic retinochoroiditis — the other major infectious cause of necrotizing retinitis in this population — is the degree of vitreous inflammation. CMV retinitis characteristically shows relatively little vitritis, precisely because the degree of immunosuppression required to develop CMV retinitis in the first place is severe enough to blunt the inflammatory response that would otherwise cloud the vitreous. Toxoplasmosis, by contrast, produces marked vitritis — the classic "headlight in the fog" appearance, in which the retinal lesion itself is hazily obscured by dense overlying vitreous inflammation. A retinitis with a sharply visible, well-demarcated lesion and minimal vitreous haze in a profoundly immunosuppressed patient should raise CMV well above toxo on the differential, not the other way around.

Progressive Outer Retinal Necrosis

Progressive outer retinal necrosis (PORN) is caused by varicella-zoster virus (VZV) in severely immunocompromised patients, again typically with a CD4+ count below 50 cells/mm³. It is rapidly progressive and multifocal, beginning peripherally and spreading with a speed that can produce bilateral blindness within days if untreated. Like CMV retinitis, PORN shows minimal vitritis — this is the feature that distinguishes it from acute retinal necrosis (ARN) in immunocompetent hosts, where VZV or HSV produce a similar necrotizing retinitis but with substantial vitreous inflammatory reaction. The combination of a VZV-driven necrotizing retinitis with little to no vitritis, in a patient with advanced immunosuppression, is the signature of PORN rather than conventional ARN.

AIDS-Defining Malignancy & Opportunistic Skin/Surface Disease

Several additional findings cluster in advanced HIV/AIDS outside the retina itself:

Kaposi sarcoma, caused by human herpesvirus 8 (HHV-8), is the most common ocular or periocular malignancy in AIDS. It most often involves the conjunctiva or eyelids, presenting as a reddish-purple, vascular-appearing lesion that can be mistaken for a subconjunctival hemorrhage or a hordeolum before biopsy.

Herpes zoster ophthalmicus occurs with markedly increased incidence in HIV-infected patients compared to the general population, and when it does occur it tends to be more severe, more prolonged, and more atypical in presentation, with a higher rate of recurrence than in immunocompetent individuals.

Molluscum contagiosum eyelid lesions are a useful sentinel finding: multiple or atypical molluscum lesions in an adult should prompt consideration of underlying HIV infection. In advanced HIV/AIDS specifically, these lesions tend to become more numerous, larger ("giant" molluscum), and more resistant to spontaneous resolution, reflecting the impaired cell-mediated immunity needed to clear the poxvirus.

Ocular surface squamous neoplasia (OSSN) is more common in HIV-positive patients, and HIV infection functions as an independent risk factor beyond UV exposure alone — likely through impaired immune surveillance of oncogenic HPV-infected and UV-damaged conjunctival/corneal epithelial cells. OSSN in HIV-positive patients also tends to present at a younger age and behave more aggressively than in HIV-negative patients with otherwise similar UV exposure.

Ocular syphilis co-infection is both more common and often more severe in HIV-coinfected patients, presenting as panuveitis, chorioretinitis, or optic neuritis. Because presentations can be atypical and aggressive in this population, a high index of suspicion for syphilis co-infection is warranted in any HIV-positive patient with unexplained intraocular inflammation.

Finally, conjunctival microvasculopathy — segmented columns of blood ("sludging") in conjunctival vessels, with dilated, irregular capillaries and microaneurysm formation — is an often asymptomatic finding in HIV infection, essentially the conjunctival analog of the retinal microvasculopathy described above.

Diagnosis / Workup

Most infectious retinitis in advanced HIV/AIDS is diagnosed clinically, from the characteristic fundus appearance described above combined with the patient's known CD4 count. When the presentation is atypical, definitive diagnosis relies on PCR analysis of aqueous or vitreous fluid for CMV DNA — this is more reliable in equivocal cases than serum CMV IgG titer, autofluorescence imaging, or OCT alone, none of which reliably confirm active retinitis on their own.

Because CMV retinitis is frequently asymptomatic in its earliest stages, screening matters as much as reactive diagnosis: patients with a CD4+ count below 50 cells/µL should undergo a dilated fundus screening exam every three months, specifically to catch early, asymptomatic retinitis before it threatens central vision.

Management

First-line treatment for CMV retinitis is oral valganciclovir, which has excellent oral bioavailability and reliably achieves therapeutic intraocular drug levels — a major advantage over its predecessor, IV ganciclovir, for most patients. Intravitreal ganciclovir implants or systemic foscarnet/cidofovir are reserved for sight-threatening disease (e.g., lesions immediately threatening the macula or optic nerve) or for disease refractory to first-line therapy.

A distinct and easily missed complication arises after antiretroviral therapy is started in a patient with a history of CMV retinitis: immune recovery uveitis. As CD4 counts rise and cell-mediated immunity is restored, the immune system mounts a newly vigorous inflammatory response to residual CMV antigen still present in previously affected retina. This presents with vitritis, cystoid macular edema, and epiretinal membrane formation — inflammatory findings that can be mistaken for recurrent active CMV retinitis rather than recognized as a separate, immune-reconstitution driven process. It is managed with periocular or systemic corticosteroids alongside continued antiviral therapy, not with an increase in antiviral dosing alone.

Related Topics

Continue exploring Systemic Disease & the Eye: